Your Article Summary
Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
Cell Therapeutics, 06/18/09
Cell Therapeutics, Inc. announced the preliminary results of its separate concurrent fixed price exchange offers for any and all of the approximately $118.9 million outstanding principal amount of five series of its convertible notes. The Exchange Offers expired at New York City time, on Tuesday, June 2009.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
A look at how far hospitals have come since To Err is Human report
American Hospital Association News, 11/25/09
AstraZeneca and the Philadelphia Department of Public Health provide free medicines to Pennsylvanias uninsured
AstraZeneca, 11/24/09
Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
Amgen, 11/24/09
Article Search
Sponsor


See Latest Articles


